Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings reports from some major firms. The healthcare industry also had its fair ...
It looks like there could be trouble in paradise for Katie Price and JJ Slater as the Married At First Sight UK star is reportedly growing tired of being the former glamour model's 'doormat'.
HealthDay News — The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu. This ...
In the five years since the Boston Red Sox traded homegrown superstar Mookie Betts to the Los Angeles Dodgers, what was once New England’s most sacred public institution has remained stuck in re ...
Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech that'll never recover its former glory -- which it built on the success of ...
Moderna's stock roared higher on the back of news about potential AI mRNA vaccines. The company also secured a supply contract in Europe. Shares of Moderna are down 90%, and the company has a huge ...
Sales at the once-high-flying biotech will likely continue to shrink for a while. But Moderna has a new cash cow in development, along with other potential winners. The U.S. government should ...
A school board in Passaic County agreed to pay $400,000 to settle a lawsuit after a high school baseball coach said he was forced out of his job during a battle with the team’s booster club.
Diablo 4 devs decided to keep the Welcome Back Booster in the game - here's what it does if you missed out (Image via Blizzard Entertainment) The Season 6 update of Diablo 4 introduced the Welcome ...
The American pharmaceutical company Moderna is developing an mRNA-based vaccine candidate for norovirus, designated as mRNA-1403. This vaccine is designed to protect against multiple norovirus ...
Following four straight sessions of gains, Moderna (NASDAQ:MRNA) shares continued to trade higher in the premarket on Friday after the company received a tender to supply its COVID-19 vaccine in ...
Moderna secures a multi-year agreement to supply its COVID-19 vaccine to 17 European countries, including Norway and North Macedonia. Vaccine formats include prefilled syringes, reducing ...